XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Explore Which Performs Better Total Return Vs Price Index and understand the circumstances under which each metric shines for investors.
26,851 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Geopolitics can move markets fast. When tensions rise, like with Iran, volatility spikes and portfolios feel the stra...
A larger stock buyback authorization sent BlackLine's shares higher, signaling confidence from management. This analy...
As tech markets evolve into 2026, two giants dominate discussions about broad exposure and concentration. This articl...
Tariff headlines keep markets guessing. This guide shows how two Vanguard index funds outperformed the S&P 500 in 202...
Kick off your week with focused investing insights. This Sunday Reads edition distills 10 essential topics—from low-c...
Looking for a simple, cost-effective way to access the U.S. stock market? This guide breaks down the no-brainer right...
Renting a car can be cheaper than you think—until taxes and fees show up. This guide explains why those charges pile ...
An experienced investment banker explains why pension funds stick with complex alternatives even when a simple 60/40 ...
Deciding how to own the S&P 500 can feel overwhelming. This guide breaks down the pros and cons of RSP versus VOO, sh...
Two crypto treasury desks, Sharplink and Forward, are joining Russell’s U.S. index family, signaling growing mainstre...
The NEOS Nasdaq-100 High Income ETF (QQQI) is delivering a high monthly payout via an option overlay, but the strateg...